1
TITLE: Targeting lysyl oxidases for breast cancer therapy: bioinformatic analysis and evaluation of 4-thiazolidinone derivatives as LOXL2 inhibitors
AUTHORS: Ferreira, S.; Ramos, S.; Holota, S.; Khyluk, D.; Lesyk, R.; Saraiva, N.; Fernandes, A. S.;
PUBLISHED: 2022, SOURCE: FEBS OPEN BIO, VOLUME: 12
INDEXED IN: WOS